Navigation Links
Study finds monarch butterflies use medicinal plants to treat offspring for disease
Date:10/10/2010

Monarch butterflies appear to use medicinal plants to treat their offspring for disease, research by biologists at Emory University shows. Their findings were published online Oct. 6 in the journal Ecology Letters.

"We have shown that some species of milkweed, the larva's food plants, can reduce parasite infection in the monarchs," says Jaap de Roode, the evolutionary biologist who led the study. "And we have also found that infected female butterflies prefer to lay their eggs on plants that will make their offspring less sick, suggesting that monarchs have evolved the ability to medicate their offspring." (See interview with de Roode here: http://tinyurl.com/3995m3u)

Few studies have been done on self-medication by animals, but some scientists have theorized that the practice may be more widespread than we realize. "We believe that our experiments provide the best evidence to date that animals use medication," de Roode says.

"The results are also exciting because the behavior is trans-generational," says Thierry Lefevre, a post-doctoral fellow in de Roode's lab. "While the mother is expressing the behavior, only her offspring benefit. That finding is surprising for monarch butterflies."

The findings also may have implications for human health, says University of Michigan chemical ecologist Mark Hunter, who collaborated with de Roode's group on the research.

"When I walk around outside, I think of the plants I see as a great, green pharmacy," Hunter says. "But what also strikes me is how little we actually know about what that pharmacy has to offer. Studying organisms engaged in self-medication gives us a clue as to what compounds might be worth investigating for their potential as human medicines."

Monarch butterflies are known for their spectacular migration from the United States to Mexico each year, and for the striking pattern of orange, black and white on their wings. That bright coloration is a warning sign to birds and other predators that the butterfly may be poisonous.

Monarch caterpillars feed on any of dozens of species of milkweed plants, including some species that contain high levels of cardenolides. These chemicals do not harm the caterpillars, but make them toxic to predators even after they emerge as adults from their chrysalises.

Previous research has focused on whether the butterflies choose more toxic species of milkweed to ward off predators. De Roode wondered if the choice could be related to the Ophryocystis elektroscirrha. The parasites invade the gut of the caterpillars and then persist when they become adult monarchs. An infected female passes on the parasites when she lays her eggs. If the adult butterfly leaves the pupal stage with a severe parasitic infection, it begins oozing fluids from its body and dies. Even if the butterflies survive, they do not fly as well or live as long as uninfected ones.

Experiments in de Roode's lab have shown that a female infected with the parasites prefers to lay her eggs on a toxic species of milkweed, rather than a non-toxic species. Uninfected female monarchs, however, showed no preference.

Researchers have studied the kinds of leaves that primates eat in forests, but this work with butterflies stresses the point that even insects in our own back yard can be useful indicators of what might be medicinally active, Hunter says.


'/>"/>

Contact: Beverly Clark
beverly.clark@emory.edu
404-712-8780
Emory University
Source:Eurekalert

Related biology news :

1. Long-term study shows effect of climate change on animal diversity
2. £2 million study to reveal workings of dementia genes
3. New study looks to define evangelicals and how they affect polling
4. CU-Boulder study suggests air quality regulations miss key pollutants
5. Researchers study acoustic communication in deep-sea fish
6. Study reveals homeowner perceptions in fire-prone areas
7. Researchers study how pistachios may improve heart health
8. Study: urban black bears live fast, die young
9. New study indicates link between weight gains during pregnancy and dieting history
10. Study reveals specific gene in adolescent men with delinquent peers
11. Sweat it out: UH study examines ability of sweat patches to monitor bone loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... RPS ... clinical study that demonstrates the accuracy of the FebriDx® test, a commercially-ready, ... acute bacterial and viral respiratory tract infections by testing the body’s immune ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: